330 related articles for article (PubMed ID: 10554799)
1. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.
Morgenstern GR; Prentice AG; Prentice HG; Ropner JE; Schey SA; Warnock DW
Br J Haematol; 1999 Jun; 105(4):901-11. PubMed ID: 10554799
[TBL] [Abstract][Full Text] [Related]
2. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.
Huijgens PC; Simoons-Smit AM; van Loenen AC; Prooy E; van Tinteren H; Ossenkoppele GJ; Jonkhoff AR
J Clin Pathol; 1999 May; 52(5):376-80. PubMed ID: 10560360
[TBL] [Abstract][Full Text] [Related]
4. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
5. An update to the cost-effectiveness of posaconazole vs fluconazole or itraconazole in the prevention of invasive fungal disease among neutropenic patients in the United States.
Sung AH; Marcella SW; Xie Y
J Med Econ; 2015 May; 18(5):341-8. PubMed ID: 25524741
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
Vardakas KZ; Michalopoulos A; Falagas ME
Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United States.
O'Sullivan AK; Pandya A; Papadopoulos G; Thompson D; Langston A; Perfect J; Weinstein MC
Value Health; 2009; 12(5):666-73. PubMed ID: 19508661
[TBL] [Abstract][Full Text] [Related]
9. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
Cornely OA; Maertens J; Winston DJ; Perfect J; Ullmann AJ; Walsh TJ; Helfgott D; Holowiecki J; Stockelberg D; Goh YT; Petrini M; Hardalo C; Suresh R; Angulo-Gonzalez D
N Engl J Med; 2007 Jan; 356(4):348-59. PubMed ID: 17251531
[TBL] [Abstract][Full Text] [Related]
10. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Harousseau JL; Dekker AW; Stamatoullas-Bastard A; Fassas A; Linkesch W; Gouveia J; De Bock R; Rovira M; Seifert WF; Joosen H; Peeters M; De Beule K
Antimicrob Agents Chemother; 2000 Jul; 44(7):1887-93. PubMed ID: 10858349
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
[TBL] [Abstract][Full Text] [Related]
12. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of itraconazole in the prophylaxis of invasive fungal infections.
de Vries R; Daenen S; Tolley K; Glasmacher A; Prentice A; Howells S; Christopherson H; de Jong-van den Berg LT; Postma MJ
Pharmacoeconomics; 2008; 26(1):75-90. PubMed ID: 18088160
[TBL] [Abstract][Full Text] [Related]
15. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
Prentice AG; Glasmacher A; Djulbegovic B
Br J Haematol; 2006 Mar; 132(5):656-8; author reply 658-9. PubMed ID: 16445845
[No Abstract] [Full Text] [Related]
16. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.
Wang J; Zhan P; Zhou R; Xu J; Shao X; Yang Y; Ouyang J
Med Oncol; 2010 Dec; 27(4):1082-8. PubMed ID: 19876778
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of different prophylactic antifungal regimens in bone marrow transplantation.
Annaloro C; Oriana A; Tagliaferri E; Bertolli V; Della Volpe A; Soligo D; Ibatici A; Pozzoli E; Lambertenghi Deliliers GL
Haematologica; 1995; 80(6):512-7. PubMed ID: 8647515
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
